[Event Report] Joint Japan/ UK Science and Policy Workshop (March 4-5, 2024, Shinjuku-ku, Tokyo)
date : 4/2/2024
Tags: AMR
![[Event Report] Joint Japan/ UK Science and Policy Workshop (March 4-5, 2024, Shinjuku-ku, Tokyo)](https://hgpi.org/en/wp-content/uploads/sites/2/HGPI_20240304_AMR_01-scaled-1.jpg)
On March 4 and 5, Health and Global Policy Institute (HGPI) Manager Ms. Yui Kohno presented at the Joint Japan/ UK Science and Policy Workshop which was held in Shinjuku-ku, Tokyo, Japan.
The Joint Japan/ UK Science and Policy Workshop was hosted by the National Centre for Global Health and Medicine (NCGM) and Sir Howard Dalton Centre (HDC), and the University of Warwick. The workshop gathered stakeholders from science, policy, academia, industry, and philanthropy to address how new national and international cross-sectoral partnerships might work together in a sustainable manner for future antibiotic discovery.
Session 3 (Part 1) featured speakers on the theme of “Industry-Academia Collaboration for Sustainable Capacity Building in Antibiotic Drug Discovery – Next Generation Scientists, Lessons from Past Experiences, and Future Plans.”
The lecture concluded with a panel discussion and Q&A.
Chair
UK – Annette von Delft (Centre for Medicines Discovery, Oxford University)
Japan – Yui Kohno (Health and Global Policy Institute (HGPI))
Panelists (Speaking Order)
Dave Powell (Chief Scientific Officer, LIfeArc)
Manabu Sumi (Cabinet Councillor, Cabinet Agency for Infectious Disease Crisis Management, Cabinet Secretariat)
Takuko Sawada (Director of the Board and Executive Vice President, Shionogi & Co.)
Munehiro Asally (Associate Professor, School of Life Sciences, University of Warwick)
Related Posts
-
2023-12-08
[Event Report] Joint Congress on Global Health 2023 Symposium “AMR as a Global Health Challenge” (64th Japanese Society of Tropical Medicine Conference, 38th Japanese Society of Global Health Conference, 27th Japanese Society of Travel Medicine Conference, 8th International Clinical Medicine Conference, November 24, 2023, Bunkyo City, Tokyo)
-
2023-12-08
[Event Report] Joint meeting of the 72nd East Japan Regional Meeting of the Japanese Society of Infectious Diseases and the 70th East Japan Branch Meeting of the Japanese Society of Chemotherapy Symposium "Actions against AMR and New AMR National Action Plan 2023-2027" (October 25, 2023, Bunkyo-ku, Tokyo)
-
2023-09-13
[Activity Report] Recommendations for Creating a Sustainable Innovation Ecosystem for Antimicrobial R&D (August 1, 2023)
-
2023-08-29
[Event Report] APEC Workshop “Incentives to Bring New Antibiotics to APEC Markets” (July 31, August 1, 2023, Seattle, USA)
-
2023-07-24
[In the media] “Tech-powered War on AMR” (BioSpectrum Asia Edition, July 4, 2023)
-
2023-05-12
[Activity Report] Recommendations to Prime Minister Fumio Kishida on the issue of antimicrobial resistance (AMR) in the G7 Hiroshima Summit Leaders’ Declaration (April 28, 2023)
-
2023-03-09
[Activity Report] HGPI Manager Attends “Universal Health Coverage (UHC) in an Era of Antimicrobial Resistance (AMR) and Pandemics" (February 21-22, 2023)
-
2023-01-23
[Activity Report] “AMR & JAPAN’S G7 PRESIDENCY: A Call for Pull Incentives to Drive Innovation” (December 13, 2022)
Top Research & Recommendations Posts
- [Research Report] The 2025 Public Opinion Survey on Healthcare in Japan (March 17, 2025)
- [Research Report] Perceptions, Knowledge, Actions and Perspectives of Healthcare Organizations in Japan in Relation to Climate Change and Health: A Cross-Sectional Study (November 13, 2025)
- [Policy Recommendations] The Path to a Sustainable Healthcare System: Three Key Objectives for Public Deliberation (January 22, 2026)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Policy Recommendations] Reshaping Japan’s Immunization Policy for Life Course Coverage and Vaccine Equity: Challenges and Prospects for an Era of Prevention and Health Promotion (April 25, 2025)
- [Research Report] Survey of Japanese Physicians Regarding Climate Change and Health (December 3, 2023)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
- [Policy Recommendations] Mental Health Project: Recommendations on Three Issues in the Area of Mental Health (July 4, 2025)
- [Publication Report] Planetary Health Promotion Project “Issues Facing Planetary Health and the Role of the Health Sector” (May 10, 2023)
- [Announcement] HGPI Endorses the “Belém Health Action Plan” (November 14, 2025)
Featured Posts
-
2025-12-11
[Event Report] Core Components of Universal Health Coverage (UHC): Achieving “Healthcare Without Financial Hardship” in Asia-Pacific and Japan (December 5, 2025)
![[Event Report] Core Components of Universal Health Coverage (UHC): Achieving “Healthcare Without Financial Hardship” in Asia-Pacific and Japan (December 5, 2025)](https://hgpi.org/en/wp-content/uploads/sites/2/HGPI_20251210_Core-Components-of-Universal-Health-CoverageUHC-top.jpg)
-
2026-01-09
[Registration Open] (Hybrid Format) Dementia Project FY2025 Initiative Concluding Symposium “The Future of Dementia Policy Surrounding Families and Others Who Care for People with Dementia” (March 9, 2026)
![[Registration Open] (Hybrid Format) Dementia Project FY2025 Initiative Concluding Symposium “The Future of Dementia Policy Surrounding Families and Others Who Care for People with Dementia” (March 9, 2026)](https://hgpi.org/en/wp-content/uploads/sites/2/dementia-20260309-top.png)
-
2026-01-22
[Policy Recommendations] The Path to a Sustainable Healthcare System: Three Key Objectives for Public Deliberation (January 22, 2026)
![[Policy Recommendations] The Path to a Sustainable Healthcare System: Three Key Objectives for Public Deliberation (January 22, 2026)](https://hgpi.org/en/wp-content/uploads/sites/2/is-20260122-top_ENG.png)
-
2026-01-26
[HGPI Policy Column] (No.68) – From the Intractable and Rare Diseases Project “Part 2 – Making Intractable and Rare Diseases a Priority Issue for the International Community: The WHA Resolution’s Vision for a Global Action Plan and Japan’s Role”
![[HGPI Policy Column] (No.68) – From the Intractable and Rare Diseases Project “Part 2 – Making Intractable and Rare Diseases a Priority Issue for the International Community: The WHA Resolution’s Vision for a Global Action Plan and Japan’s Role”](https://hgpi.org/en/wp-content/uploads/sites/2/Eyecatch_Column_RD_2-1.png)
-
2026-01-26
[Policy Recommendations] Reshaping Japan’s Immunization Policy for Life Course Coverage and Vaccine Equity: Challenges and Prospects for an Era of Prevention and Health Promotion (April 25, 2025)
![[Policy Recommendations] Reshaping Japan’s Immunization Policy for Life Course Coverage and Vaccine Equity: Challenges and Prospects for an Era of Prevention and Health Promotion (April 25, 2025)](https://hgpi.org/en/wp-content/uploads/sites/2/vc-20250425-top.jpg)
